Vice President at Charles River Associates
Daniel M McGavock is vice president and IP practice leader of Charles River Associates (CRA), a global business, financial and economics consulting firm. Mr McGavock has specialised in the valuation and strategic management of intellectual property for more than 30 years. He has provided expert testimony in over 80 IP matters and has experience in a variety of forums, including arbitral tribunals, federal courts, state courts, the US Court of Claims, the International Trade Commission and the Patent Trial and Appeal Board. He has addressed all areas of potential economic recovery in IP disputes, including lost profits, price erosion, reasonable royalty, fair, reasonable and non-discriminatory licensing terms, profit disgorgement and unjust enrichment. He has also addressed the issues of commercial success and the economic impact of injunctions. Outside litigation, Mr McGavock has performed IP valuations in a variety of contexts, including licence and joint venture transactions, M&A transactions, bankruptcy/restructuring, transfer pricing and financial/tax reporting. He has assisted clients throughout the IP strategic management and transaction process, including in portfolio assessment, opportunity identification, competitive benchmarking, market research, partner screening, financial modelling, transaction negotiation and licence compliance audits.
His industry experience includes aerospace, automotive, chemicals and materials, computer hardware and peripherals, consumer products, defence technology, energy, environmental, financial services, food and beverage, industrial equipment, internet businesses, medical devices, media/entertainment, mobile devices, pharmaceuticals, semiconductors, social media, software, telecommunications and wireless technology. Before CRA’s acquisition of InteCap in 2004, Mr McGavock served as InteCap’s president and as a member of its board of directors. Mr McGavock is a registered certified public accountant and a Certified Licensing Professional. He has served as chair of the Licensing Executives Society Valuation and Taxation and Financial Markets Committees, as vice chair of the International Audit Committee and as a founding member of the Biopharmaceutical Royalty Rates and Deal Terms Global Survey Committee. Mr McGavock is an adjunct professor at the Northwestern University Pritzker School of Law, teaching a course on IP valuation.